UPDATE 1-Regulus hep C combination drug effective in mid-stage study

Feb 17 (Reuters) - Regulus Therapeutics Inc said interim data showed that patients tested with its hepatitis C drug combination treatment displayed sustained viral response in an ongoing mid-stage...